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Abstract: Given the alarming increase in colorectal cancer (CRC) worldwide, novel therapies are
urgently needed. Plant-derived extracts have gained considerable interest in the last years due to
their strong anticancer effect mediated by their unique bioactive compounds. Specifically, rosehips
from Rosa canina have been successfully tested against several cancer models, including colon
cancer. Moreover, gold derivatives are a promising alternative to the current platinum-based drugs
commonly used in CRC chemotherapy due to their lack of affinity for DNA. Herein we have
investigated the antitumor potential of a drug combination made of acidic polyphenols extracted from
R. canina and the gold complex (Au(C≡C-2-NC5H4) (PTA)) in Caco-2 cell line as a model of CRC. The
combination triggered strong apoptosis mediated by a blockage of the autophagic flux, which might
be a consequence of a reactive oxygen species (ROS) increase and mitochondrial dysfunctionality.
Our results suggest that the clinical application of plant polyphenols might enhance the anticancer
effect of metallodrugs and reduce drug exposure time and therefore its side effects.
Keywords: apoptosis; autophagy; colorectal cancer; rosehip; gold complex; ROS
1. Introduction
The high incidence of cancer worldwide, along with the incomplete efficacy of current therapies,
drives the development of novel clinical strategies to reduce mortality and improve patients’ quality of
life. A growing body of evidence supports the potential use of certain phytocompounds that are able
to kill cancer cells by inhibiting key enzymes or altering their genomic expression [1,2]. Therefore, the
use of whole-plant extracts and/or isolated fractions that contain more than one bioactive compound
might be a better approach to cancer therapy due to the additive effect of single agents. In line with
this thinking, plant extracts have been proposed as promising adjuvants for chemotherapeutic drugs
in order to enhance their effectiveness [3,4] as well as to improve its cytotoxicity on healthy tissue [5,6].
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Rosa canina is a widespread wild plant whose rosehips have been used in traditional medicinal
remedies in Europe, Asia, and North America [7]. Rosehips have a high content of ascorbic acid,
phenolic compounds and other bioactive molecules that are considered responsible for their therapeutic
potential. In the last years, rosehips from R. canina have been successfully tested on various cancer cell
lines including colon, lung and prostate, suggesting their potential role on chemotherapy [8].
Among all types of tumor, colorectal cancer (CRC) is the second most diagnosed cancer in women
and the third in men, and is the fourth most common cause of all cancer-related deaths. Although
a small percentage of all diagnosed cases are due to inherited mutations, in most cases CRC onset
is closely related to lifestyle factors including consumption of red meat, sedentarism or tobacco
smoking. In light of this, the fast increase of CRC in developing countries due to the acquisition of
so-called ‘Western-like’ lifestyle habits is not surprising but is a matter of concern [9–11]. CRC therapy
usually consists of a combination of surgery and chemotherapy, with the cisplatin analogue oxaliplatin
being one of the most common drugs. However, the use of platinum-containing drugs is associated
with severe side effects due to their lack of selectivity for tumor cells. Gold-based drugs have been
suggested as an alternative, since instead of interacting with DNA these complexes display high
affinity for proteins overexpressed on tumor cells such as thioredoxin reductase or the proteasome
system [12,13]. Therefore, gold derivatives might be considered as a safer therapeutic strategy than the
current platinum-containing drugs.
Given the promising antitumoral potential of combinations of metallodrugs and plant
extracts [3,4,14] along with our previous work, we have developed a new chemotherapy combination
focused on CRC treatment. This drug combination is composed of the alkynyl gold(I) complex
(Au(C≡C-2-NC5H4)(PTA)) (PTA = 1,3,5-triaza-7-phosphadamantane) [15,16] and acidic polyphenols
(AP) extracted from the rosehips of Rosa canina [17]. The objectives of the present work were the
analysis of the combined effect of the acidic polyphenols and the gold complex in order to assess the
AP fraction as a potential adjuvant agent for organometallic-based chemotherapy, the characterization
of the effect of the resulting drug combination in terms of the type of cell death, and the putative
mechanisms of action. This study has been carried out in the human colorectal adenocarcinoma cell
model Caco-2 cell line.
2. Materials and Methods
2.1. Preparation, Purification and Fractioning of R. canina Acidic Polyphenols
The work was carried out with rosehips from the plant species Rosa canina harvested in the year
2014. The company, which provided the rosehip samples, is Herbes del Molí (Alicante, Spain) and
the company has the necessary permissions for this type of activity. The samples do not belong to a
species in danger of extinction nor are they protected. The rosehips were collected in the mountain of
Mariola in a landscape called "Ca’l retor", located in the municipality of Agres (Alicante), with the
permission of the owner, D. Fidel Pascual Molins. In that geographical zone, the winters are cold, with
temperatures as low as −15 ◦C, while the summers are hot, with temperatures that can go higher than
35 ◦C or even 40 ◦C. Rainfall is irregular and can vary from 350 to 900 mm/annually. Freshly collected
rosehips were stored at −40 ◦C prior to analysis.
The composition of polyphenols from the rosehip sample of Rosa canina used in the present
study is shown by Jiménez et al. [17]. The average values in µg/kg dried fruit of the polyphenols are:
myricetin, 5.4; rutin 22; catechin 11.9; quercetin 1.5; vanillic acid 260; caffeic acid 2; syringic acid 110;
gallic acid 298; ellagic acid 80 and protocatechuic acid 210. To carry out this study only the acidic
fraction of the polyphenols present in the rosehips was taken (vanillic acid, caffeic acid, syringic acid,
gallic acid, ellagic acid and protocatechuic acid), which was separated from the rest of the neutral
polyphenols. The separation of both fractions is described in Jiménez et al. [17].
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2.2. HPLC Analysis of Polyphenols of Rosehips
Analysis was performed using high-pressure liquid chromatography (Waters Chromatography
Div., Milford, MA, USA) equipped with two 515 pumps, a 717 autosampler and a 996 Photodiode
Array Detector. Two mobile phases A (0.1% phosphoric acid) and B (acetonitrile) both from Scharlab,
were used. The flow rate was 1 mL/min with the linear gradient profile: 0–20 min, from 10% to 22%
B; 21–40 min, from 22% to 40% B; 41–50 min, from 40% to 55% B; 51–60 min, from 55% to 10% B;
61–65 min, equilibration at 10% B. The injection volume of sample, dissolved in methanol, was 10 µL.
The column used was a reverse phase Atlantis dC18 (150 mm × 4.6 mm i.d., 5 µm particle size). The
chromatographic control was performed with Empower 2.0 software (Waters, Milford, MA, USA). The
criteria for identification of the different compounds was the double coincidence of the UV-visible
spectrum at wavelengths characteristic of each compound and the chromatographic retention times
compared with corresponding standards. The quantification was achieved using calibration curves at
five different concentrations of the standard.
2.3. Synthesis of (Au(C≡C-2-NC5H4)(PTA))
The gold complex was prepared as previously described [15]. Briefly: to a solution of KOH
(0.4 mmol) in MeOH (10 mL) containing 2-ethynylpyridine (0.3 mmol) was added [AuCl(PTA)]
(0.26 mmol). After stirring the mixture for ~20 h the solid was isolated by filtration and washed with
diethyl ether.
2.4. Cell Culture
Human Caco-2 cell line (TC7 clone) was kindly provided by Edith Brot-Laroche (Université
Pierre et Marie Curie-Paris 6, UMR S 872, Les Cordeliers, France). Caco-2 cells were maintained in a
humidified atmosphere of 5% CO2 at 37 ◦C. Cells (passages 50–80) were grown in Dulbecco’s Modified
Eagles Medium (DMEM) (Gibco Invitrogen, Paisley, UK) supplemented with 20% fetal bovine serum
(FBS), 1% non-essential amino acids, 1% penicillin (1000 U/mL), 1% streptomycin (1000 µg/mL) and 1%
amphotericin (250 U/mL). The cells were passaged enzymatically with 0.25% trypsin-1 mM EDTA and
sub-cultured on 25 cm2 plastic flasks at a density of 2 × 104 cells/cm2. Culture medium was replaced
every 2 days. Drug treatments were added 24 h post-seeding for assays on undifferentiated cells; for
assays on differentiated cells, treatments were added 1-week post-seeding on 96-wells plates [18]. Cell
confluence (80%) was confirmed by optical microscopy observance (Figure S1).
2.5. Cell Treatment
Acidic polyphenols from R. canina were diluted in cell culture medium to the required concentration
(IC50 value: 125 µg/mL) [17].
Gold complex was diluted in dimethyl sulfoxide (DMSO) at 2 mM and then in cell culture medium
to the required concentration (IC50 value: 3.8 µM) [16].
For treatment with the drug combination, the required concentrations of acidic polyphenols and
gold complex were added to the same falcon tube with cell culture medium, then vortex and incubated
with Caco-2 cells. For isobologram plotting [19,20], IC50 of GC was re-calculated in presence of two
concentrations of AP, namely 62.5 and 31.25 µg/mL. The obtained values were 1.26 and 2.04 respectively.
Then, the additivity line was plotted using the original IC50 values for both GC and AP and the location
of the points (1.26, 62.5) and (2.04, 31.25) suggested an additive effect.
2.6. Cell Viability Assay
For cytotoxicity screening assays, Caco-2 cells were seeded in 96-well plates at a density of
4 × 103 cells/well. Culture medium was replaced with medium containing drug panel, and cells were
incubated for 24, 48 or 72 h. Antiproliferative effect was measured with the sulforhodamine B (SRB)
assay as previously described [17]. Absorbance at 540/620 nm was measured with SPECTROstar Nano
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(BMG Labtech, Ortenberg, Germany). The effect on cell growth was expressed as a percentage of
the control.
2.7. Measurements of Apoptosis
Caco-2 cells were seeded in 25 cm2 flasks and then exposed to drug panel for 48 h, then collected
and stained with annexin V-FITC and propidium iodide according to manufacturer’s instruction. Cells
were then transferred to flow cytometry tubes and washed twice with phosphate saline buffer (PBS),
followed by a resuspension in 100 µL of annexing V-binding buffer (100 mM HEPES/NaOH pH 7.4,
140 nM NaCl, 2.5 mM CaCl2). Additions of 5 µL annexin V-FITC and 5 µL propidium iodide were
made to each tube. After 15 min of incubation at room temperature covered from light, 400 µL of
annexin-binding buffer were added to each sample and signal intensity was analyzed within 1 h with
FACSARIA BD. Data were analyzed with FACSDIVA BD (v7, BD Franklin Lakes, NJ, USA).
2.8. Analysis of the Activation of Caspase 3
Caco-2 cells were seeded in 25 cm2 flasks and then exposed to drug panel for 48 h, then collected
and fixed with 0.01% formaldehyde for 15 min. After 5 min centrifugation at 300 g, the pellet was
resuspended in 100 µL of 0.5% v/v digitonin solution and incubated 15 min protected from light.
Cells were washed with 0.1% v/v digitonin solution and centrifuged for 5 min at 300 g. The pellet
was resuspended in 0.1% digitonin and anti-caspase 3 (Novus, clone C92-605) was added to each
sample and incubated for 1h. Cells were then centrifuged 5 min at 500 g, washed twice with PBS and
resuspended in PBS. Fluorescence was analyzed with FACSARRAY BD equipped with an argon ion
laser. Ex: 394–400; Em: 495–505.
2.9. Cell Cycle Analysis
Caco-2 cells were seeded in 25 cm2 flasks and then exposed to the drug panel for 48 h, then
collected and fixed in 70% ice-cold ethanol at 4 ◦C for 24 h. After 5 min centrifugation at 2500 rpm, cells
were rehydrated in PBS and stained with 50 µg/mL propidium iodide solution. Red fluorescence was
collected with a 620 nm long pass filter as a measure of the amount of PI bounded to DNA. Percentage
of cells on each cell cycle phase was determined with MODIFIT 3.0 verity software (BD Franklin Lakes,
NJ, USA).
2.10. Determination of RIP-1 Protein Amount by Flow Cytometry
Caco-2 cells were seeded in 25 cm2 flasks and then exposed to the drug panel for 48 h, then
collected and the determination of receptor–interaction protein kinase 1 (RIP-1) levels was performed
as previously described [16].
2.11. Measurement of Autophagosome Formation
Caco-2 cells were seeded in 96-well plates at a density of 4 × 103 cells/well and then incubated with
the drug panel for 1 or 24 h. For autophagosomes formation, Autophagy Assay Kit (Sigma–Aldrich,
San Luis, MO, USA) was used according to manufacturer’s instruction. Fluorescence intensity
(λex = 360/λem = 520 nm) was measured with FLUOstar Omega (BMG Labtech, Ortenberg, Germany).
Fluorescence intensity was normalized with cell viability for assays at 24 h incubation. The obtained
values of fluorescence intensity are considered a reflection of total autophagosome formation.
2.12. Determination of Intracellular Levels of Reactive Oxygen Species (ROS)
Caco-2 cells were seeded in 96-well plates at a density of 4 × 103 cells/well and then incubated
with drug panel for 1 or 24 h. Determination of intracellular H2O2 formation was performed
using the dichlorofluorescein (DCF) assay as previously described [21]. Fluorescence intensity
(λex = 485/λem = 535 nm) was measured with FLUOstar Omega (BMG Labtech, Ortenberg, Germany),
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and was normalized with cell viability for assays at 24 h incubation. The obtained values of fluorescence
intensity are considered a reflection of total intracellular reactive oxygen species (ROS) content.
2.13. Flow Cytometry Mitochondrial Membrane Potential Assay
Caco-2 cells were seeded in 25 cm2 flasks and then exposed to drug panel for 24 or 48 h, then
collected and washed twice with PBS. The pellet was resuspended in PBS at a concentration of 106
cell/mL and 5 µL of 10 µM 1,1’,3,3,3’-hexamethylindodicarbo-cyanine iodide (DiIC1) were added to
each sample. Tubes were incubated at 37 ◦C for 15 min and 400 µL PBS were added prior to analyze
fluorescence with FACSARRAY BD equipped with an argon ion laser, Ex: 633 nm; Em: 658 nm.
2.14. Determination of Lysosome Alkalization
Caco-2 cells were seeded in 25 cm2 flasks and then exposed to the drug panel for 24 or 48 h,
then collected and changes in lysosomal acid content measured with LysoTracker Green DND-26
(Molecular Probes™ L7526). The dye was first diluted on DMEM to a concentration of 75 nM. Then,
1 mL of diluted LysoTracker was added to each 50 µL of cell sample. Cells were incubated 2 h at room
temperature kept in darkness and then were centrifuged 5 min at 1200 rpm. Pellet was resuspended on
200 µL phosphate buffered saline (PBS) and fluorescence signal (λex = 504/λem = 511 nm) was analyzed
by FACSARIA BD equipped with an argon ion laser.
2.15. Statistical Analysis
All assays were performed at least three times. Data are presented as mean ± SD. Data were
subjected to one-way analysis of variance (ANOVA) and LSD–Fisher post hoc test. Differences were
considered significant at p ≤ 0.05.
3. Results and Discussion
3.1. Acidic Polyphenols from R. canina Enhance the Antiproliferative Effect of Gold Complex
The antiproliferative effect of the acidic polyphenols fraction (AP) of rosehips from R. canina on
Caco-2 cell line after 72 h of incubation were previously evaluated by us [17], reading an IC50 value of
125 µg/mL. On the other hand, the effect of the gold complex (Au(C≡C-2-NC5H4)(PTA)) towards the
same cell model displayed a higher in vitro effect than plant extracts with an IC50 value of 3.8 µM [16].
Initially, a range of concentrations of acidic polyphenols (125, 62.5 and 31.25 µg/mL) was tested in
combination with the gold complex at its IC50 value for 72 h (Figure 1A). Results obtained showed the
key role of AP concentration on the antiproliferative effect of drug combination, since all the tested
concentration values decreased cell viability in comparison to both negative control and cells treated
with the gold complex as a single agent (p < 0.05). In order to analyze whether the observed results
were a consequence of synergy or additivity, the kind of pharmacological interaction between single
agents was further studied with an isobologram (Figure 1B), after re-calculation of the corresponding
IC50 values of the gold complex in the presence of both concentrations of AP (62.5 and 31.25 µg/mL),
which afforded the IC50 values of 1.25 and 2.04 µM respectively, versus the previous value of 3.8 µM
obtained with the gold complex alone. As can be observed on Figure 1B, the combination of the gold
complex and AP showed additive cytotoxicity on Caco-2 cell line.
Then, time-course analyses were performed after 24, 48 and 72 h of incubation (Figure 1C).
Incubation time was found to be crucial for the antiproliferative effect of the drug combination, since it
induced significant changes in cell viability (p < 0.05) at short-time incubation (24 h) whereas for the
gold complex these changes were not observed until 48 h. Moreover, the drug combination induced a
50% reduction on cell viability upon 48 h of incubation, whereas single agents reached that effect after
72 h.
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and 72 h) determination of changes in Caco-2 cells viability upon treatment with 3.8 μM of the gold 
complex (GC), 125 μg/mL of acidic polyphenols (AP) and a combination of both (DC) at the indicated 
concentrations. #p < 0.05 vs gold complex (GC). 
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Caco-2 cells undergo spontaneous differentiation after reaching confluence and acquire the
orphology and enzy atic profile of a ature enterocyte [22]. Thus, differentiated Caco-2 cells are
considered as an acceptable model of the intestinal barrier and have been traditionally used to evaluate
the toxicity of novel drugs on a non-cancerous model [23]. The drug combination and AP did not
induce significant changes on cell proliferation of differentiated Caco-2 cells after long-term incubation
(72 h) (Figure S2), which might suggest that such combination displays selectivity for this cancer type.
It has been reported that plant extracts and plant metabolites ight display a different behavior on
cancer and non-cancer cells. As a part of normal diet, they are well-tolerated by non-cancer cells,
whereas are harmful for cancer cells. Ivanova et al. [24] observed resveratrol-induced cell death of
Jurkat cells but not influenced cell viability rates of normal lymphocytes. In this context, plant extracts
have been proposed as co-adjuvants to ameliorate side effects caused by chemotherapeutic drugs such
as cisplatin given their antioxidant and anti-inflammatory properties [25,26]. In the specific case of
differentiated Caco-2 cells, Di Nunzio et al. [27] found that olive pomace successfully protected this
intestinal barrier model from inflammation induced by the addition of interleukin-1β. Therefore, it
is feasible to suppose that R. canina extract might protect differentiated Caco-2 cells by the oxidative
and/or inflammatory damage induced by the gold co plex.
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3.2. Drug Combination Triggers Apoptosis on Caco-2 Cells
We found it interesting to analyze the type of cell death induced by the combination of the extracts
and the gold complex on undifferentiated Caco-2 cells.
After 48-h incubation with drug combination, 2.8-fold increase in late apoptotic population and a
2.5-fold increase in early apoptotic cells were observed, whereas no significant changes in the necrotic
cell population were found (Figure 2A). Furthermore, a 5.44-fold increase in active caspase 3 (Figure 2B)
along with cell cycle arrest on G1 phase (Figure 2C) were observed at 48 h. Taken together, these results
suggest that the drug combination induced apoptosis on Caco-2 cells. Its pro-apoptotic effect might be
a direct consequence of the concomitant administration of the gold complex and the acidic polyphenols
fraction, since incubation with single agents did not induce significant changes on apoptotic cells
population after 48 h of incubation (Figure S3).
In a previous work [16], we reported that 24 h incubation with the gold complex
(Au(C≡C-2-NC5H4)(PTA)) induced Caco-2 cell death by a programmed form of necrosis called
necroptosis, which is caspase-independent. Interestingly, treatment of cell culture with the drug
combination for 48 h did not modify the number of cells with activated receptor–interaction protein
kinase 1 (RIP-1), one of the key regulators of necroptosis [28], which suggests that the necroptotic
pathway is non-activated by the drug combination (Figure S4). Moreover, pre-incubation of cell culture
with the RIP-1 inhibitor necrostatin-1 (Nec-1) (50 µM, 1h) resulted in no significant changes in cell
viability in comparison with the administration of drug combination in the absence of Nec-1 (Table 1),
which further confirmed that no necroptosis was triggered by the drug combination.
Antioxidants 2019, 8, x FOR PEER REVIEW 7 of 12 
After 48-h incubation with drug combination, 2.8-fold increase in late apoptotic population and 
a 2.5-fold increase in early apoptotic cells were observed, whereas no significant changes in the 
necrotic cell population were found (Figure 2A). Furthermore, a 5.44-fold increase in active caspase 
3 (Figure 2B) along with cell cycle arrest on G1 phase (Figure 2C) were observed at 48 h. Taken 
together, these r sults suggest that the drug combinati n induce  apoptosis on Caco-2 cells. Its ro-
apoptotic ffect might be a direct consequence of the concomitant administratio  of the gold complex 
and the acidic polyphenols fraction, since incubation with single agents did not induce significant 
changes on apoptotic cells population after 48 h of incubation (Figure S3). 
In a previous work [16], we reported that 24 h incubation with the gold complex (Au(C≡C–2–
NC5H4)(PTA)) induced Caco-2 cell death by a programmed form of necrosis called necroptosis, which 
is caspase-independent. Interestingly, treatment of cell culture with the drug combination for 48 h 
did not modify the number of cells with activated receptor–interaction protein kinase 1 (RIP-1), one 
of the key regulators of necroptosis [28], which suggests that the necroptotic pathway is non-activated 
by the drug combination (Figure S4). Moreover, pre-incubation of cell culture with the RIP-1 inhibitor 
necrostatin-1 (Nec-1) (50 μM, 1h) resulted in no significant changes in cell viability in comparison 
with the administration of drug combination in the absence of Nec-1 (Table 1), which further 
onfi med that no n croptosis was triggered by the drug combination.  
 
Figure 2. Cell death studies. (A) Flow cytometry histogram corresponding to Caco-2 cells stained with 
annexin V/propidium iodide 48 h after incubation with DMSO (negative control, left) and drug 
combination (DC, right). X-axis annexin-FITC and Y-axis propidium iodide. Q1: necrotic cells. Q2: 
late apoptotic cells. Q3: living cells. Q4: early apoptotic cells. Percentages of cell population in each 
condition are included. (B) Analysis of caspase 3 activation of Caco-2 cells 48 h after incubation with 
DC; *p < 0.05 vs negative control. (C) Flow cytometry cell cycle analysis with propidium iodide 
staining of Caco-2 cells 48 h after incubation with DC (control, left). Percentages of cell population in 
each cell cycle phase are included. 
Table 1. Cell viability. Measurement of cell viability of Caco-2 cells upon 24 h treatment with DC in 
presence or not of necrostatin-1 (50 μM, 1 h pre-incubation).  
Figure 2. Cell death studies. (A) Flow cytometry histogram corresponding to Caco-2 cells stained
with a nexin V/prop dium io ide 48 h after incubation with DMSO (negative control, left) and drug
combination (DC, right). X-axis an exin-FI is ropidium io ide. Q1: necrotic cells. Q2:
late apopt tic cells. Q3: living cells. Q4: e l totic cells. Percentages of cell opulation in each
condition are include . (B) Analysis of caspase 3 activation of Caco-2 cells 48 h after incubation with
DC; * p < 0.05 vs negative control. (C) Flow cyto etry cell cycle analysis with propidium iodide
staining of Caco-2 cells 48 h after incubation with DC (control, left). Percentages of cell population in
each cell cycle phase are included.
Antioxidants 2020, 9, 17 8 of 12
Table 1. Cell viability. Measurement of cell viability of Caco-2 cells upon 24 h treatment with DC in
presence or not of necrostatin-1 (50 µM, 1 h pre-incubation).
% Cell viability
Control 100 ± 0.00
DC 69.27 ± 0.64*
DC+Nec-1 72.14 ± 6.61*
No significant changes were observed between DC with/without Nec-1. * p < 0.05 vs control.
Shen and Codogno [29] found that the inhibition of necroptosis led to cell death by apoptosis.
In light of this finding, the high rates of apoptotic cells observed on Figure 2A might be a consequence
of the disruption of the necroptotic process induced by the concomitant administration of acidic
polyphenols and the gold complex. In line with this, autophagy seems to play a key role in both
inhibition and promotion of other forms of cell death given its dual cytoprotective and cytotoxic
nature. Some authors have reported that activation of cytoprotective autophagy might be related
to necroptosis inhibition [30,31]. Since 48 h of treatment with the drug combination resulted in no
evidence of necroptosis activation, a likely activation of cytoprotective autophagy must be an upstream
event. Therefore, changes in autophagosome formation were analyzed after 24 h incubation. As can be
observed in Figure 3A, the drug combination induced a 1.5-fold increase in autophagosomes formation,
whereas the gold complex and AP separately did not induce any significant changes (Figure S5).
Consequently, the concomitant administration of both drugs triggers autophagy, which might be
related to the absence of necroptosis previously discussed.
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Figure 3. Analysis of autophagy induction. (A) Measurement of changes in the formation of
autophagosomes on Caco-2 cells 24 h after incubation with DC. * p < 0.05 vs negative control.
(B) Measurement of cell viability of Caco-2 cells upon 24 h and 72 h treatment with drug combination
(DC) in presence/absence of chloroquine (10 µM, 1 h pre-incubation); * p < 0.05 vs negative control. No
significant changes were observed in comparison to cells DC with/without CQ.
Interestingly, pre-incubation of Caco-2 cells with the autophagy inhibitor chloroquine (CQ) (10 µM,
1 h) resulted in no significant changes in cell viability when comparing with cells non-treated with
CQ after 24 h or 72 h treatment with the drug combination (Figure 3B). The autophagic process
consists of two stages: the early stage comprises the formation of the autophagosome, which engulfs
damaged subcellular structures as well as protein aggregates, whereas in the late stage the fusion of
autophagosome and lysosome ends with the digestion of the non-functional cellular components [32].
Given that CQ inhibits late autophagy by preventing the autophagosome–lysosome fusion, our data
suggest that the autophagic process is initiated upon treatment with the drug combination, although
autophagy might not display a significant role on its antiproliferative effect. In fact, uncompleted
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autophagy has been related to high rates of apoptosis due to the accumulation of non-functional
cellular structures [33,34]. Therefore, it is feasible to hypothesize that the observed strong pro-apoptotic
effect induced by the drug combination (Figure 2A) might be a consequence of a blockage of the
autophagic flux.
3.3. Drug Combination Disrupts Redox Homeostasis, Which Induces Mitochondrial Disturbances along with
Lysosomal Dysfunction
In an effort to determine whether treatment with the drug combination triggered uncompleted
autophagy, we analyzed lysosomal integrity 24 h and 48 h after incubation (Table 2). We observed a
time-dependent loss of acidification that correlates with lysosomal impairment. As aforementioned,
drug-mediated induction of lysosome alkalization has been related to a blockage of the autophagic flux
and high rates of apoptosis [33,34], and mitochondrial dysfunction is considered to be one of the main
causes of the impairment of lysosomes [35]. With this in mind, changes in mitochondrial membrane
potential (ψm) were analyzed after 24 h and 48 h incubation with the drug combination (Table 2). We
found a time-dependent increase in cell population with an altered value of ψm, which suggests a
disruption on normal mitochondrial function. Since a significant loss of ψm was noticed after 24 h,
prior to lysosomal alkalization (Table 2), mitochondrial dysfunction seems to be an upstream event
relative to lysosomal impairment.
Table 2. Analysis of lysosomal and mitochondrial integrity. Above: percentages of Caco-2 cells with
functional (acid) lysosomes upon 24 h and 48 h incubation with the drug combination (DC). Below:
changes in mitochondrial membrane potential (ψm) of Caco-2 cells after 24 h and 48 h incubation
with DC.
% Cells with Functional (Acid) Lysosomes
24 h 48 h
Negative control 85.50 ± 3.11 94.10 ± 2.26
DC 85.55 ± 1.62 74.95 ± 1.62*
% Cells with Conservedψm
24 h 48 h
Negative control 100.00 ± 0.00 100.00 ± 0.00
DC 61.98 ± 10.68* 27.25 ± 8.52*
* p < 0.05 vs negative control.
Finally, we measured reactive oxygen species (ROS) levels due to their key role in mitochondrial
homeostasis. A significant increase in ROS production was observed after a short incubation time (1 h)
and it was maintained upon overnight treatment with the drug combination (Table 3). The role of
ROS on cell death was further confirmed by pre-incubation of Caco-2 cells with the ROS scavenger
N-acetylcysteine (NAC) (3 mM, 1 h), which reduced the great decrease in cell viability caused by 72 h
treatment with the drug combination (Table 3). Therefore, our data suggest that disruption of redox
balance and mitochondrial dysfunction with lysosomal impairment and autophagy blockage triggered
by drug combination, results in apoptotic cell death.
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Table 3. Role of reactive oxygen species (ROS) levels on cell death triggered by DC. Above: measurement
of ROS levels expressed as arbitrary units of fluorescence in Caco-2 cells incubated for 1 h and 24 h with
the drug combination (DC). Fluorescence data were normalized with cell viability. Below: analysis of
Caco-2 cell viability pre-incubated with NAC and then treated 24 h and 72 h with DC.
ROS levels (Arbitrary Units)
1 h 24 h
Negative control 1 ± 0.00 1 ± 0.00
DC 1.32 ± 0.10* 1.31 ± 0.04*
% Cell Viability
24 h 72 h
Negative control 100 ± 0.00 100 ± 0.00
DC 68.13 ± 7.73* 27.94 ± 1.50*
DC + NAC 72.42 ± 0.47* 80.16 ± 2.52*#
* p < 0.05 vs negative control. # p < 0.05 vs treatment with DC.
4. Conclusions
We have investigated the anticancer potential of a novel drug combination made from the
acidic polyphenols extracted from rosehips of the wild plant Rosa canina and the gold complex
(Au(C≡C-2-NC5H4)(PTA)). Assays performed on the human colorectal adenocarcinoma Caco-2 cell
line showed that the addition of increasing concentrations of acidic polyphenols significantly enhanced
the antiproliferative effect of the gold derivative, and reduced the drug exposure time necessary to
obtain a significant decrease in viability of cancer cells. The resulting drug combination triggered
strong apoptosis that might be a consequence of a blockage of the autophagic flux. Regarding the
unpaired autophagy, the marked pro-oxidant effect of the drug combination led to a disruption of
mitochondrial function, which might be responsible for the lysosome alkalinization observed. To our
knowledge, this is the first in-vitro study that analyzes the potential antitumor effect of a combination
of a plant-derived extract and a gold complex. Taken together, our results suggest a potential role
of plant polyphenols as adjuvant for gold-based drugs on colorectal cancer therapy. Future studies
will be necessary to determine the possible interaction between polyphenols and ligands of the gold
complex tested.
Supplementary Materials: The following are available online at http://www.mdpi.com/2076-3921/9/1/17/s1,
Figure S1. Optical phase contrast microscopy at 20X magnification of Caco-2 cells. Above: differentiated cells
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undifferentiated cells at 24 h post-seeding, (b) undefined cytoplasmic membrane and round shape. The low
density seed cells shows a bigger size than the differenced cells. Figure S2: title: Measurement of differentiated
Caco-2 cells viability 72 h after incubation with drug combination (DC). Figure S3. Title: Cell death analysis of
Caco-2 cells viability 48 h after incubation. Figure S4. Title: Flow cytometry analysis of the expression levels
of RIP-1 on Caco-2 cells 48 h after incubation. Figure S5. Title: Measurement of changes in the formation of
autophagosomes in Caco-2 cells at 24 h post-incubation.
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